How a kinase inhibitor withstands gatekeeper residue mutations

Scientists from TIFR, Mumbai and Columbia University, USA team up to understand the binding mechanism of kinase inhibitors—a step toward designing better inhibitors.


This is a companion discussion topic for the original entry at https://indiabioscience.org/news//how-a-kinase-inhibitor-withstands-gatekeeper-residue-mutations.